Maynard Um
-
-
-
-
-
-
-
CytoMed Therapeutics (GDTC) first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneicCAR-T cell against blood and solid tumors received co-funding support from the NMRC Clinic
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

